AKR7L

gene
On this page

Also known as AFAR3

Summary

AKR7L (aldo-keto reductase family 7 like (gene/pseudogene), HGNC:24056) is a protein-coding gene on chromosome 1p36.13, encoding Aflatoxin B1 aldehyde reductase member 4 (Q8NHP1). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol.

This gene is one of three aldo-keto reductase genes that are present in a cluster on the p arm of chromosome 1. The encoded proteins are involved in the reduction of the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. It has been speculated that this family member encodes a selenoprotein, which includes a selenocysteine (Sec) residue in lieu of a UGA translational termination codon. However, there is no evidence that such a protein is produced in vivo. The alternative interpretation is that this family member is a segregating pseudogene, where some individuals have an allele that encodes a functional enzyme, while other individuals have an allele encoding a protein that is predicted to be non-functional.

Source: NCBI Gene 246181 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 6 total — 1 pathogenic

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:24056
Approved symbolAKR7L
Namealdo-keto reductase family 7 like (gene/pseudogene)
Location1p36.13
Locus typegene with protein product
StatusApproved
AliasesAFAR3
Ensembl geneENSG00000211454
Ensembl biotypeprotein_coding
OMIM608478
Entrez246181

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding_LoF, 1 retained_intron

ENST00000429712, ENST00000457194, ENST00000493176

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000429712 — 7 exons

ExonStartEnd
ENSE000015042611926927219269371
ENSE000016272901926958319269679
ENSE000017191561927386119274194
ENSE000017553371926710319267461
ENSE000034765531927074819270935
ENSE000036752631926857219268701
ENSE000037159041927045119270555

Expression profiles

Bgee: expression breadth ubiquitous, 132 present calls, max score 95.35.

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
duodenumUBERON:000211495.35gold quality
right lobe of liverUBERON:000111493.11gold quality
liverUBERON:000210790.53gold quality
body of pancreasUBERON:000115087.45gold quality
small intestine Peyer’s patchUBERON:000345485.43gold quality
mucosa of transverse colonUBERON:000499185.17gold quality
body of stomachUBERON:000116184.93gold quality
small intestineUBERON:000210884.57gold quality
stomachUBERON:000094582.00gold quality
fundus of stomachUBERON:000116081.52gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047379.64gold quality
transverse colonUBERON:000115778.52gold quality
adult mammalian kidneyUBERON:000008278.37gold quality
cortex of kidneyUBERON:000122576.91gold quality
pancreasUBERON:000126476.78gold quality
metanephros cortexUBERON:001053376.44gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099176.01gold quality
cerebellar hemisphereUBERON:000224574.77gold quality
kidneyUBERON:000211374.76gold quality
cerebellar cortexUBERON:000212974.70gold quality
cerebellumUBERON:000203774.66gold quality
intestineUBERON:000016074.14gold quality
right hemisphere of cerebellumUBERON:001489073.94gold quality
rectumUBERON:000105273.46gold quality
gall bladderUBERON:000211072.69gold quality
mucosa of stomachUBERON:000119972.06gold quality
colonUBERON:000115570.49gold quality
skin of legUBERON:000151166.98gold quality
olfactory segment of nasal mucosaUBERON:000538666.92gold quality
nucleus accumbensUBERON:000188266.59gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.24

Regulation

Is transcription factor: no

Cross-species orthologs

12 orthologs

OrganismSymbolGene ID
danio_rerioakr7a3ENSDARG00000016649
mus_musculusAkr7a5ENSMUSG00000028743
rattus_norvegicusAkr7a2ENSRNOG00000017780
drosophila_melanogasterCG6083FBGN0036183
drosophila_melanogasterCG18547FBGN0037973
drosophila_melanogasterCG3397FBGN0037975
caenorhabditis_elegansWBGENE00003176
caenorhabditis_elegansWBGENE00009980
caenorhabditis_elegansWBGENE00009981
caenorhabditis_elegansWBGENE00012722
caenorhabditis_elegansWBGENE00012723
caenorhabditis_elegansWBGENE00015307

Paralogs (16): AKR7A2 (ENSG00000053371), KCNAB2 (ENSG00000069424), AKR1B1 (ENSG00000085662), AKR1A1 (ENSG00000117448), AKR1D1 (ENSG00000122787), AKR1C2 (ENSG00000151632), AKR7A3 (ENSG00000162482), AKR1E2 (ENSG00000165568), KCNAB1 (ENSG00000169282), KCNAB3 (ENSG00000170049), AKR1C1 (ENSG00000187134), AKR1C3 (ENSG00000196139), AKR1B10 (ENSG00000198074), AKR1C4 (ENSG00000198610), AKR1B15 (ENSG00000227471), AKR1C8 (ENSG00000264006)

Protein

Protein identifiers

Aflatoxin B1 aldehyde reductase member 4Q8NHP1 (reviewed: Q8NHP1)

Alternative names: AFB1 aldehyde reductase 3, Aldoketoreductase 7-like

All UniProt accessions (0):

UniProt curated annotations — full annotation on UniProt →

Function. Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.

Tissue specificity. Mainly expressed in uterus.

Polymorphism. The sequence shown in this entry differs from the translation of the reference genome assembly (GRCh38/hg38) due to a nonsense variant creating stop codon at position 106 in the reference genome. This sequence carries a selenocysteine-insertion element (SECIS)-like structure that during translation may recode an in-frame TGA-stop codon to a selenocysteine. However, there is no evidence that such a protein is produced in vivo. The sequence shown in this entry is that of variant p.Ter106Arg. This variant has a frequency of about 3% in the human population according to the Genome Aggregation Database (gnomAD v3.1.2).

Similarity. Belongs to the aldo/keto reductase family. Aldo/keto reductase 2 subfamily.

Isoforms (2)

UniProt IDNamesCanonical?
Q8NHP1-11yes
Q8NHP1-32

RefSeq proteins (0): (*=MANE)

Domains & families (InterPro)

IDNameType
IPR023210NADP_OxRdtase_domDomain
IPR036812NAD(P)_OxRdtase_dom_sfHomologous_superfamily
IPR050523AKR_Detox_BiosynthFamily

Pfam: PF00248

UniProt features (17 total): binding site 8, sequence variant 3, chain 1, active site 1, site 1, modified residue 1, splice variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NHP1-F195.890.95

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (2): 49 (proton donor); 77 (lowers pka of active site tyr)

Ligand- & substrate-binding residues (8): 44; 113; 143–144; 169; 198–208; 222; 232; 290–298

Post-translational modifications (1): 85

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-5423646Aflatoxin activation and detoxification

MSigDB gene sets: 17 (showing top): REACTOME_BIOLOGICAL_OXIDATIONS, WCTCNATGGY_UNKNOWN, GATA1_01, GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS, chr1p36, GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY, REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION, GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY, GOMF_OXIDOREDUCTASE_ACTIVITY, MEBARKI_HCC_PROGENITOR_FZD8CRD_DN, BUSSLINGER_GASTRIC_PARIETAL_CELLS, BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES, DESCARTES_FETAL_PANCREAS_ACINAR_CELLS, E2F_Q2, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN

GO Biological Process (0):

GO Molecular Function (2): oxidoreductase activity (GO:0016491), alcohol dehydrogenase (NADP+) activity (GO:0008106)

GO Cellular Component (6): cytoplasm (GO:0005737), cytosol (GO:0005829), extracellular exosome (GO:0070062), nuclear envelope (GO:0005635), smooth endoplasmic reticulum (GO:0005790), Golgi apparatus (GO:0005794)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Biological oxidations1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
cytoplasm2
endomembrane system2
catalytic activity1
alcohol dehydrogenase [NAD(P)+] activity1
intracellular anatomical structure1
extracellular vesicle1
nucleus1
organelle envelope1
endoplasmic reticulum1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

0 interactions, top by confidence (×1000):

IntAct

10 interactions, top by confidence:

ABTypeScore
PEF1PDCD6psi-mi:“MI:0914”(association)0.900
AKR7A3AKR7A2psi-mi:“MI:0914”(association)0.890
AKR7A3ASAH1psi-mi:“MI:0914”(association)0.530
SCRIBCHD2psi-mi:“MI:0914”(association)0.350
AKR7LKIF2Apsi-mi:“MI:0914”(association)0.350
AKR7A2DCTN6psi-mi:“MI:0914”(association)0.350
KCTD13SMTNpsi-mi:“MI:0914”(association)0.350

ESM2 similar proteins: A1YER2, A1YFX9, A2T7G9, A6NNS2, B0BN93, B0BNF8, O22718, O35331, O35678, O75911, O77769, O80526, O88876, O95154, P11172, P14755, P15904, P84169, Q06136, Q15738, Q1RMJ5, Q28DS0, Q2KIJ5, Q2QNG7, Q2QZ86, Q3SZM9, Q3T067, Q3ZBE9, Q5E964, Q5I0K3, Q5PPL3, Q5R514, Q5R5C9, Q5RDZ2, Q6AY30, Q6UWP2, Q811X6, Q86WA6, Q8JGT5, Q8K183

Diamond homologs: A0A0F7TN16, A0A0U5GHU6, A0A5B8YXI2, C7ZBE5, C8VQ93, M2YJQ2, M2YMU7, O43488, O95154, P25612, P38918, P42884, P43546, P43547, P47182, Q00049, Q00258, Q00727, Q01333, Q01752, Q07747, Q08361, Q6Q875, Q6UEH5, Q75ZG2, Q75ZG3, Q8CG45, Q8CG76, Q8NHP1, A0A3B1EFQ1, A0QJ99, A2XRZ0, A2XRZ6, B8ASB2, C6TBN2, F4HPY8, K3VD70, O14125, O14295, O22707

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

6 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance0
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
1228381GRCh37/hg19 1p36.13-36.12(chr1:16785250-23491592)x1Pathogenic

SpliceAI

989 predictions. Top by Δscore:

VariantEffectΔscore
1:19267458:CACC:Cacceptor_gain1.0000
1:19267460:CC:Cacceptor_gain1.0000
1:19267461:CC:Cacceptor_gain1.0000
1:19267462:C:CCacceptor_gain1.0000
1:19268697:AGAAG:Aacceptor_gain1.0000
1:19268698:GAAG:Gacceptor_gain1.0000
1:19268699:AAG:Aacceptor_gain1.0000
1:19268700:AG:Aacceptor_gain1.0000
1:19268701:GCTG:Gacceptor_loss1.0000
1:19268702:C:CCacceptor_gain1.0000
1:19268703:T:Gacceptor_loss1.0000
1:19268707:C:CTacceptor_gain1.0000
1:19268708:A:Tacceptor_gain1.0000
1:19268709:G:Cacceptor_gain1.0000
1:19268709:G:GCacceptor_gain1.0000
1:19268715:A:ACacceptor_gain1.0000
1:19269270:A:ACdonor_gain1.0000
1:19269271:C:CTdonor_gain1.0000
1:19269274:ATT:Adonor_gain1.0000
1:19269276:T:TAdonor_gain1.0000
1:19269294:A:ACdonor_gain1.0000
1:19269295:C:CCdonor_gain1.0000
1:19269581:ACCAG:Adonor_gain1.0000
1:19269582:CCAGC:Cdonor_gain1.0000
1:19269676:TGCC:Tacceptor_gain1.0000
1:19269678:CC:Cacceptor_gain1.0000
1:19269679:CC:Cacceptor_gain1.0000
1:19269680:C:CAacceptor_loss1.0000
1:19269680:C:CCacceptor_gain1.0000
1:19269681:T:Cacceptor_loss1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000526528 (1:19273545 A>G), RS1001293736 (1:19273736 G>A,C,T), RS1001857246 (1:19269182 G>A), RS1002788470 (1:19266584 G>T), RS1002902932 (1:19266317 G>GTTTA,GTTTC), RS1003525686 (1:19275205 G>A), RS1003850561 (1:19265732 G>C,T), RS1005015505 (1:19265696 T>G), RS1005646816 (1:19272952 C>G,T), RS1005861520 (1:19271920 A>G), RS1006026288 (1:19267014 A>G), RS1006102320 (1:19268301 G>C), RS1006549563 (1:19266643 A>G), RS1007659974 (1:19272218 C>A), RS1008383430 (1:19274447 C>A,G,T)

Disease associations

OMIM: gene MIM:608478 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST000597_10Brain structure1.000000e-07
GCST007001_1Cerebrospinal AB1-42 levels in normal cognition5.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004670beta-amyloid 1-42 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

11 total (human), top 11 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, decreases expression2
aristolochic acid Iincreases expression1
sodium arseniteincreases expression1
butyraldehydedecreases expression1
perfluorooctane sulfonic aciddecreases expression1
fipronilaffects cotreatment, decreases expression1
DEETaffects cotreatment, decreases expression1
Xylitolincreases expression1
Oleic Aciddecreases expression1
Okadaic Aciddecreases expression1
S-Nitrosoglutathionedecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.